Business
Innocan Pharma Announces Details of Proposed Share Consolidation
Innocan Pharma Corporation ("Innocan" or the "Company") (CSE: INNO) (FSE: IP4) (OTCQB: INNPF) is pleased to announce that further to its press release dated July 23, 2025, it will be consolidating all of its issued and outstanding common shares ("Common Shares") on the basis of one (1) post-consolidation Common Share for each 65 pre-consolidation Common Shares (the "Share Consolidation"). The Share Consolidation represents another step towards the completion of a proposed public offering of unit
About this update from Innocan Pharma Corporation
[{"type":"text","content":"HERZLIYA, Israel and CALGARY, Alberta, Aug. 29, 2025 /CNW/ -- Innocan Pharma Corporation ("Innocan" or the "Company") (CSE: INNO) (FSE: IP4) (OTCQB: INNPF) is pleased to announce that further to its press release dated July 23, 2025, it will be consolidating all of its issued and outstanding common shares ("Common Shares") on the basis of one (1) post-consolidation Common Share for each 65 pre-consolidation Common Shares (the "Share Consolidation"). The Share Consolidation represents another step towards the completion of a proposed public offering of units (the "Units") in the United States as set out in its registration statement on Form F-1 that has been publicly filed with the U.S. Securities and Exchange Commission (the "SEC") and the listing of the Common Shares on the NASDAQ Capital Market ("NASDAQ").","length":894,"tagName":"p"},{"type":"image","alt":"Innocan_Pharma_Logo","displaySize":"","headline":null,"caption":"Innocan_Pharma_Logo","className":"","disableSlideshowImg":false,"size":{"original":{"width":400,"height":283,"url":"https://media.zenfs.com/en/cnwgroup.com/7706f970d25ba77672f989a1db7cd166"},"resized":{"url":"https://s.yimg.com/ny/api/res/1.2/MQ_objxOFBZ.dAp8fl2HIw--/YXBwaWQ9aGlnaGxhbmRlcjt3PTcwNTtoPTQ5OTtjZj13ZWJw/https://media.zenfs.com/en/cnwgroup.com/7706f970d25ba77672f989a1db7cd166","width":400,"height":283}}},{"type":"text","content":"Each Unit will be comprised of one common share of the Company (a "Common Share") and one common share purchase warrant of the Company (a "Warrant"). Each Warrant will entitle the holder thereof to purchase one Common Share at an exercise price and term in the context of the market.","length":303,"tagName":"p"},{"type":"text","content":"Innocan has applied to list its Common Shares and Warrants on the Nasdaq Capital Market under the symbols "INNP" and "INNPW", respectively.","length":159,"tagName":"p"},{"type":"text","content":"ThinkEquity LLC is acting as representative underwriter in the offering.","length":72,"tagName":"p"},{"type":"text","content":"This proposed offering will be made only by means of a prospectus. Upon availability, copies of the preliminary prospectus related to the proposed offering may be obtained from ThinkEquity, 17 State Street, 41st&...